This inventor holds 1 USPTO granted patent. Top assignees: Hodogaya Chemical Co., Ltd., Mochida Pharmaceutical Co., Ltd.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1992
Title: Hitoshi Inaba: Innovator in Pharmaceutical Chemistry
Introduction
Hitoshi Inaba is a notable inventor based in Shinjuku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent related to novel compounds with therapeutic applications. His work has implications for the treatment of various medical conditions.
Latest Patents
Hitoshi Inaba holds a patent for a compound known as 4,5-dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid. This invention pertains to novel compounds that exhibit potent hypotensive, anti-oedematous, and diuretic effects. The patent also details processes for producing these compounds and their intermediate forms, which are crucial for synthesizing the final products. The compounds are particularly useful in treating diseases related to fluid retention and hypertension.
Career Highlights
Throughout his career, Hitoshi Inaba has worked with prominent companies in the pharmaceutical industry, including Mochida Pharmaceutical Co., Ltd. and Hodogaya Chemical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.
Collaborations
Hitoshi Inaba has collaborated with esteemed colleagues such as Kazumi Nishijima and Kazuo Kato. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Hitoshi Inaba's contributions to pharmaceutical chemistry through his innovative patent demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile